Growth Metrics

Sanofi (SNY) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$8.5 billion.

  • Sanofi's Enterprise Value fell 1250.63% to -$8.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$8.5 billion, marking a year-over-year decrease of 1250.63%. This contributed to the annual value of -$8.3 billion for FY2025, which is 782.92% down from last year.
  • Sanofi's Enterprise Value amounted to -$8.5 billion in Q4 2025, which was down 1250.63% from -$10.4 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Enterprise Value registered a high of -$6.9 billion during Q1 2023, and its lowest value of -$16.7 billion during Q2 2021.
  • In the last 5 years, Sanofi's Enterprise Value had a median value of -$9.3 billion in 2024 and averaged -$10.0 billion.
  • Per our database at Business Quant, Sanofi's Enterprise Value tumbled by 6149.65% in 2021 and then skyrocketed by 3833.53% in 2023.
  • Quarter analysis of 5 years shows Sanofi's Enterprise Value stood at -$11.2 billion in 2021, then decreased by 13.03% to -$12.6 billion in 2022, then rose by 28.4% to -$9.0 billion in 2023, then rose by 16.13% to -$7.6 billion in 2024, then decreased by 12.51% to -$8.5 billion in 2025.
  • Its Enterprise Value stands at -$8.5 billion for Q4 2025, versus -$10.4 billion for Q3 2025 and -$8.4 billion for Q2 2025.